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Abstract Nucleoside analogues play an important role in
antiviral, antibacterial and antineoplastic chemotherapy.
Herein we report the synthesis, structural characterization
and biological activity of some 40-C-methyl- and -phenyl
dioxolane-based nucleosides. In particular, a and b
anomers of all natural nucleosides were obtained and
characterized by NMR, HR-MS and X-ray crystallography.
The compounds were tested for antimicrobial activity
against some representative human pathogenic fungi, bac-
teria and viruses. Antitumor activity was evaluated in a
large variety of human cancer cell-lines. Although most of
the compounds showed non-significant activity, 23a
weakly inhibited HIV-1 multiplication. Moreover, 22a and
32a demonstrated a residual antineoplastic activity, inter-
estingly linked to the unnatural a configuration. These
results may provide structural insights for the design of
active antiviral and antitumor agents.
Keywords Nucleosides  Antiviral  Antitumor  1,3-
Dioxolanes  Pyrimidines  Purines  Vorbru¨ggen reaction
Introduction
The development of nucleoside and nucleotide analogues
has been a very active research area over the past few
decades (Jordheim 2013; Romeo 2010). Modified nucleo-
sides have been employed to inhibit essential enzymes
involved in the replication pathways of many viruses
(Jordheim 2013; De Clercq 2013), parasites (Lawton 2005)
and bacteria (Van Calenbergh 2012). Moreover, nucle-
oside-based drugs have proved to be useful in chemother-
apy due to their antitumor activities (Jordheim 2013;
Mitsuya 1985). Among the useful modifications on nucle-
osides, variation of the carbohydrate moiety has been
extensively studied and several deoxynucleosides (I) and
dideoxynucleosides (II) have been discovered (Chart 1)
(Mitsuya 1985; Mitsuya 1986; Yarchoan 1988; Hamamoto
1987). However, the emergence of drug resistance and
toxicity issues remain a major cause for treatment failure,
prompting the scientific community to keep on searching
for new effective and low toxic drugs.
Recently, some 40-C-substituted nucleosides have been
reported as potent antiviral and antineoplastic agents (Wu
2013; Wang 2015; Nomura 1999). Among them, 20-deoxy-
40-C-methylcytidine revealed potent antitumor activity
in vivo (III, Chart 1) (Waga 1996; Kitano 1997). Another
structural modification of the sugar moiety has led to the
discovery of 1,3-dioxolane-based nucleosides, in which the
C–OH at 30 position has been replaced with an bioisosteric
oxygen atom (IV, Chart 1). Among them, 20,30-dideoxy-30-
oxathymidine (Dioxolane-T) and -oxacytidine (Dioxolane-
C) showed significant inhibition of the infectivity of HIV
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and HBV (Kim 1992a, b; Norbeck 1989). Dioxolane-C also
exhibited a relevant activity against solid and lymphoid
tumors both in vitro and in vivo (Grove 1995). Similarly,
20,30-dideoxy-40-C-methyl-30-oxacytidine demonstrated a
cytostatic activity against leukemia cell lines (Liu 2001). In
the purinic series, the dioxolane-guanine and dioxolane-
2,6-diaminopurine have been reported as anti-HIV-1 and
anti-HBV agents (Furman 2001; Chin 2001).
On the basis of these findings, we extended the series of
40-C-methyl dioxolane-based nucleosides and we prepared
the 40- C-phenyl analogues to verify the effect on activity
of a bulkier substituent. Herein, we report the synthesis,
structural characterization and biological evaluation of
novel 40-C-methyl and -phenyl dioxolane-based pyrimidine
and purine nucleosides (V, Chart 1).
Materials and methods
Chemistry
General
All reagents, solvents and other chemicals were used as
purchased from Sigma-Aldrich without further purification
unless otherwise specified. When air- or moisture-sensitive
reactants were employed the reactions were carried out
under nitrogen atmosphere and dry solvents, unless other-
wise noted. Flash column chromatography purifications
(medium pressure liquid chromatography) were carried out
using Merck silica gel 60 (230–400 mesh, ASTM). The
purity of the compounds was determined by elemental
analysis (C, H, N) on a Carlo Erba 1106 Analyzer. Melting
points were determined with a Stuart SMP3 and they are
uncorrected. The structures of all the isolated compounds
were ensured by nuclear magnetic resonance (NMR) and
Mass spectrometry. 1H and 13C NMR (1D and 2D exper-
iments) spectra were recorded on a DPX-200 Avance
(Bruker) spectrometer at 200 MHz and on a DPX-400
Avance (Bruker) spectrometer at 400 MHz. Chemical
shifts are expressed in d (ppm). 1H NMR chemical shifts
are relative to tetramethylsilane (TMS) as internal stan-
dard. 13C NMR chemical shifts are relative to TMS at d 0.0
or to the 13C signal of the solvent: CDCl3 d 77.04, CD3OD
d 49.8, DMSO-d6 d 39.5.
1H NMR data are reported as
follows: chemical shift, multiplicity (s, singlet; d, doublet;
t, triplet; q, quartet; m, multiplet; br, broadened), coupling
constants (Hz), number of protons, and assignment. 1H-1H
correlation spectroscopy and nuclear overhauser effect
spectroscopy (NOESY), 1H-13C heteronuclear single
quantum coherence and heteronuclear multiple bond con-
nectivity (HMBC) NMR 2D experiments were recorded for
determination of 1H-1H and 1H-13C correlations respec-
tively. The purities of the final compounds were confirmed
by elemental analysis, on a Carlo Erba 1106 Analyzer, and
the values obtained are within ±0.4 % of the calculated
ones. The exact mass of the compounds was determined by
using a Q-TOF mass spectrometer equipped with an elec-
trospray ESI or atmospheric-pressure chemical ionization
source. MS(?) spectra were acquired by direct infusion
(0.1 mL/min) of a solution containing the sample
(10 pmol/mL), dissolved in a 0.1 % acetic acid, with a
mobile phase methanol/water 50:50, at the optimum ion
voltage of 4800 V. The yields reported are based on a
single experiment and are not optimized. All the analytical
data are reported in the Supplementary Materials.
X-ray crystallography
Single-crystal X-ray structure determinations on racemates
32a and 32bH2O were carried out at 140(2) K and at room
temperature, respectively, on a Bruker-Nonius X8APEX
diffractometer equipped with Mo-Ka generator, area
detector and Kryoflex liquid nitrogen cryostat. The struc-
tures were solved in space group P-1 and successfully
refined on Fo
2 by standard methods, using SIR92 (Altomare
et al. 1993) and SHELXL-97 (Sheldrick 2008). softwares
included in the WINGX v2013.3 suite (Farrugia 2012).
Geometrical calculations were carried out using PLATON
(V-290610) (Spek 2003). All nonhydrogen atoms were
refined anisotropically. The asymmetric unit in 32a was
found heavily disordered even after expansion to space
group P1. The possibility of overlooked reciprocal lattice
layers and of an incorrectly-determined unit cell metrics
was excluded by careful examination of precession images
reconstructed from data collection frames. The two disor-
dered components correspond to the two enantiomers of
the compound and are present in a 1:1 ratio; within
experimental resolution, they share the same positions for
the phenyl atoms. Refinement was carried out by
restraining the two parts to have flat thymine moieties
Chart 1 Working hypothesis
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(within 0.05 A˚3) and to share the same geometry (1,2- and
1,3-distances equal within 0.01–0.02 A˚, respectively).
Approximate isotropic behaviour was imposed (within
0.01/0.02 A˚2 for nonterminal/terminal atoms) and neigh-
bouring atoms were forced to have similar Uij components
(within 0.01 A˚2). The phenyl ring in 32bH2O was found
disordered over two equally-populated positions rotated by
ca. 26.5 around the Cipso–C-20 bond. The two parts were
constrained to share the same Cipso atom, to be flat (as
above) and to have the same geometry (as above). The Uij
components along each rings were also restrained to be
similar (as above).
The disordered hydroxyl group in 32a was subject to
rotating group refinement (AFIX 147 instruction, with
thermal parameter U(H) = 1.5Ueq(O)). Water and hydro-
xyl hydrogen atoms in 32bH2O were located in DF maps
and fully refined with isotropic displacement parameters.
The remaining hydrogens of both compounds were set in
idealized positions and refined isotropically, with
U(H) = 1.5Ueq(X) for methyl groups and U(H) =
1.2Ueq(X) for the remaining hydrogen atoms (X is the
attached C or N atom). Torsion angle was refined for
methyl groups (AFIX 137 instruction). Crystal data and
refinement parameters for compounds 32a and 32bH2O
are given in Table S1 in Supplementary Material. Partially-
labelled ORTEP-3 (Farrugia 1997). plots are displayed.
The geometry of H-bond interactions is detailed in
Tables S2 and S3, while Table S4 gathers conformational
data for 32a, 32b H2O and related compounds. CCDC-
1055778 and 1055779 contain the supplementary crystal-
lographic data for this paper. These data can be obtained
free of charge from The Cambridge Crystallographic Data
Centre via www.ccdc.cam.ac.uk/data_request/cif.
Biological evaluation methods
Compounds were dissolved in DMSO at 200 mM and then
diluted in culture medium.
Cell lines were purchased from american type culture
collection (ATCC). The absence of mycoplasma contami-
nation was checked periodically by the Hoechst staining
method. Cell lines supporting the multiplication of HIV-1
and BVDV were CD4? human T-cells containing an
integrated HTLV-1 genome (MT-4) and Madin Darby
Bovine Kidney (MDBK), respectively. Viruses represen-
tative of positive-sense, single-stranded RNAs (ssRNA?)
were the IIIB laboratory strain of human immunodeficiency
virus type-1 (HIV-1), obtained from the supernatant of the
persistently infected H9/IIIB cells, and bovine viral diar-
rhoea virus (BVDV).
Cytotoxicity assays
Exponentially growing MT-4 cells (analogous to those
which support the replication of HIV-1) were seeded in
96-well plates, at an initial density of 1 9 105 cells/mL, in
RPMI-1640 medium supplemented with 10 % fetal bovine
serum (FBS), 100 units/mL penicillin G and 100 lg/mL
streptomycin. Cell cultures were then incubated at 37 C in
a humidified, 5 % CO2 atmosphere, in the absence or
presence of serial dilutions of test compounds. Cell via-
bility was determined after 96 h at 37 C by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
MTT method (Pauwels et al. 1998). MDBK cells were
seeded in 96-well plates, at an initial density of 6 9 105
cells/mL, in minimum essential medium with Earle’s salts
(MEM-E) containing L-glutamine (1 mM), sodium pyru-
vate (5 mM) and kanamycin (25 mg/L), supplemented
with 10 % FBS. Cell cultures were then incubated at 37 C
in a humidified, 5 % CO2 atmosphere in the absence or
presence of serial dilutions of test compounds. Cell via-
bility was determined after 48 h at 37 C by the MTT
method.
Antiviral assays
The anti-HIV-1 activity was based on inhibition of virus-
induced cytopathogenicity in exponentially growing MT-4
cell acutely infected at a multiplicity of infection (m.o.i.) of
0.01. Briefly, 50 lL of RPMI containing 1 9 104 MT-4 cells
were added to each well of flat-bottom microtitre trays con-
taining 50 lL of RPMI without or with serial dilutions of test
compounds. Then, 20 lL of a HIV-1 suspension containing
100 CCID50 were added. After 4 days of incubation at 37 C
cell viability was determined by the MTT method (Pauwels
et al. 1998). The activity against BVDV was based on inhi-
bition of the virus-induced cytopathogenicity inMDBK cells
acutely infected at a m.o.i. of 0.01. Briefly,MDBK cells were
seeded in 96-well plates at a density 3 9 104 cells/well and
were allowed to form confluent monolayers by incubating
overnight in growth medium at 37 C in a humidified CO2
(5 %) atmosphere. Cell monolayers were then infected with
50 lL of a proper virus dilution in maintenance medium
(MEM-Earl supplemented with 0.5 % inactivated FBS) to
give an m.o.i of 0.01. After 1 h, 50 lL of maintenance
medium, without or with serial dilutions of test compounds,
were added. After a 3 day incubation at 37 C, cell viability
was determined by the MTT method. Efavirenz and 20-C-
methyl-guanosinewere used as reference inhibitors of HIV-1
and BVDV, respectively.
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Antibacterial assays
Staphylococcus aureus and Salmonella spp. were recent
clinical isolates (obtained from Clinica Dermosifilopatica,
University of Cagliari). Assays were carried out in nutrient
broth (DIFCO), pH 7.2, with an inoculum of 103 bacterial
cells/tube. Minimum inhibitory concentrations (MICs)
were determined after incubation at 37 C for 18 h in the
presence of serial dilutions of test compounds (Artico et al.
1999).
Antifungal assays
Yeast inocula were obtained by properly diluting cultures
of ATCC strains incubated at 37 C for 30 h in Sabouraud
dextrose broth to obtain 5 9 103 cells/mL. Dermatophyte
inocula were obtained from cultures grown at 37 C for
5 days in Sabouraud dextrose broth by finely dispersing
clumps with a glass homogenizer and then diluting to 0.05
OD590/mL. Then, 20 lL of the above suspensions were
added to each well of flat-bottomed microtitre trays con-
taining 80 lL of medium with serial dilutions of test
compounds and were incubated at 37 C. Growth controls
were visually determined after 2 days (yeast) or 3 days
(dermatophytes) (Menozzi et al. 2004). MIC was defined as
the compound concentration at which no macroscopic sign
of fungal growth was detected. The minimal bacterici-
dal/fungicidal concentrations (MBC/MFC) were deter-
mined by subcultivating in Sabouraud dextrose agar
samples from cultures with no apparent growth. Micona-
zole and Streptomycin were used as reference compounds
in antimycotic and antibacterial assays, respectively.
Linear regression analysis
The extent of cell growth/viability or viral multiplication at
each drug concentration tested was expressed as percentage
of untreated or uninfected controls. Concentrations result-
ing in 50 % inhibition (CC50 or EC50) were determined by
linear regression analysis.
Sulforhodamine B (SRB) assay
Cells (5 9 104 cells/mM) were treated with various con-
centrations of compounds in 96-well culture plates for
72 h. After incubation, cells were fixed with 10 % tri-
chloroacetic acid, dried, and stained with 0.4 % SRB in
1 % acetic acid. The unbound dye was washed out, and the
stained cells were dried and resuspended in 10 mM Tris
(pH 10.0). The absorbance at 515 nm was measured, and
cell proliferation was determined as follows: cell prolifer-
ation (%) = (average absorbancecompound - average
absorbanceday zero) / (average absorbancecontrol - average
absorbanceday zero) 9 100 (Lee 2002). IC50 values were
calculated by nonlinear regression analysis using
Table Curve 2D v 5.01 (Systat Software Inc., Richmond,
CA, USA).
Results and discussion
Chemistry
Compounds 19223 and 31235 were prepared through the
coupling of a nucleophilic pyrimidine or purine with a
suitable 40-C-substituted sugar-like dioxolane, electrophilic
at the anomeric carbon (position 10-C) for the presence of
the acetoxy group, as described by Vorbru¨ggen (Vor-
brueggen et al. 1981).
The key intermediates (4-acetoxy-2-methyl-1,3-diox-
olan-2-yl)methyl benzoate (6) or 2-(bromomethyl)-2-phe-
nyl-1,3-dioxolan-4-yl acetate (7) were obtained by
acetalization of the appropriate ketone with glycerol
(Scheme 1) followed by oxidation and oxidative cleavage.
Briefly, the commercially available 1-hydroxypropan-2-
one, previously protected at the alcoholic function with the
benzoyl group, or 2-bromoacetophenone were reacted with
glycerol, under acidic conditions, affording a mixture of
diastereomers, 2 or 3, respectively. Oxidation of the
hydroxy group provided the corresponding carboxylic acids
4 or 5 which were subjected to oxidative decarboxylation
with lead tetraacetate providing the key intermediates 6 or 7
in good yields. Coupling of the acetoxy derivatives 6 or 7
with the silylated nucleobases, in the presence of
trimethylsilyltrifluoromethanesulfonate (TMSOTf) afforded
an almost equimolar diastereomeric mixture of a and b
anomers with respect to 10-C and 40-C of the dioxolane ring:
b[F (10-C, 40-C)] series and a[E (10-C, 40-C)] series. The
different yields so obtained (24–61 %) could be attributed
to the different basicity of the various nucleobases, with the
more basic cytosine affording the lowest yields. This trend
confirms previously reported data (Vorbrueggen et al. 1981;
Battisti et al. 2015).
Thus, depending on the reactivity of the silylated
nucleobases the Vorbru¨ggen reaction was carried out at
room temperature in dichloromethane (uracil, thymine), or
by heating in 1,2-dichloroethane (cytosine and purine).
Significantly, in the case of cytosine, heating favours the
formation of the b anomer.
For the 40-C-methyl series, the separation of the two
couples of isomers was accomplished by silica gel flash
column chromatography directly on the Vorbru¨ggen reac-
tion mixture to yield pure a and b anomers of uracil 8,
thymine 10, 6-chloropurine 15 and 2-amino-6-chloropurine
17 (Scheme 2).
S. Franchini et al.
123
Author's personal copy
In the case of the cytosine derivative 12, benzoylation of
the aminic function, to give 13, was required in order to
separate a from b. In this series, to the first eluting isomer
was assigned the a configuration based on 1H-1H NMR
experiments (see section ‘‘Structural characterization’’).
For the 40-C-phenyl series, the separation was achieved
on the acetoxy derivatives 26–30, obtained from the bro-
momethyl derivatives 9, 11,14 and 24, 25 (Scheme 3). In
the case of 24 and 25, the conversion of the 6-chloropurine
and 2-amino-6-chloropurine derivatives 16 and 18 into the
corresponding adenine and guanine derivatives was
required before the substitution reaction. Unlike the 40-C-
methyl series, the configuration assignment was opposite
and the first eluting isomer was the b anomer. As previ-
ously reported, the glycosylation reaction with the purine
nucleobases led to the formation of two regioisomers (N-7/
N-9) (Franchini et al. 2012). Reaction time, temperature
and solvent were optimized in order to guide the reaction
towards N-9 natural nucleosides. In particular, we observed
that the conversion of the probably kinetically favored N-7
into the thermodynamically more stable N-9 was achieved
by refluxing in 1,2-dichloroethane for 4-8 h. Differently, in
the case of pyrimidine nucleobases, only N-1 natural
regioisomers were obtained. Lastly, deprotection of the
hydroxyl group with NH3/MeOH at room temperature
afforded the final a and b nucleosides 19–21 (Scheme 2)
and 31–35 (Scheme 3). For the 40-C-methyl series, the final
purine nucleosides 22 and 23 were obtained from 15 to 17
after heating in a reactor in the presence of NH3/MeOH or
NaOH/MeOH, respectively (Scheme 2).
Structural characterization
The configuration of all synthesized nucleosides 19–23 and
31–35 was unambiguously assigned by 2D-NMR experi-
ments (1H-1H) of NOESY, (Fig. 1). Notice that in this
Scheme 1 Reagents and conditions: (i) PTSA, toluene, reflux, 24 h, 89 % for 2, 99 % for 3; (ii) PDC, DMF, r.t., 48 h, 37 % for 4 or KMnO4,
KOH/H2O, 80 C, 18 h, 58 % for 5; (iii) Pb(OAc)4, pyridine, EtOAc, N2, 60 C, 4–12 h, 56 % for 6, 70 % for 7; (iv) silylated base (base,
HMDS, (NH4)2SO4, N2, 120 C, 12 h), TMSOTf, N2, 0 C, CH2Cl2 (0 C to r.t.), 32 % for 8a and 29 % for 8b, 49 % for 9, 23 % for 10a and
34 % for 10b, 58 % for 11, or ClCH2CH2Cl (0 C to reflux, 4–8 h), 62 % for 12, 24 % for 14, 27 % for 15a and 32 % for 15b, 56 % for 16,
23 % for 17a and 25 % for 17b and 52 % for 18
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section the atom numbering follows IUPAC rules and, for
reasons of clarity, primed numbers are used for the diox-
olane ring.
In particular, within the methyl series a cross-peak
between H-40 and the protons of the methyl group at 20
position is indicative of a b configuration. By contrast, a
correlation between H-40 and the protons of the hydrox-
ymethyl group is observed in a anomers. The latter cor-
relation was also used to assign the configuration within the
phenyl series. These assignments were confirmed by
inspection of the chemical shifts observed in the 1H-NMR
spectra (Table 1).
In particular, for the a anomers of the methyl series,
methyl and hydroxymethyl protons undergo downfield and
upfield shifts, respectively, as compared with the corre-
sponding b anomers. These differences are attributed to the
deshielding effect exerted by the nucleobase, which is
located on the same side of the dioxolane ring as the
methyl/hydroxymethyl group in a/b anomers. These find-
ings are in accordance with those reported for other
nucleoside analogues (Kim et al. 1992a, b, 1993).
For the phenyl series the relative chemical shifts of the
proton H-40 (dioxolanyl) and H-6 (pyrimidinyl) or H-8
(purinic) were particularly informative (Table 2). In fact, in
the b-anomers the signal of the dioxolanyl proton (H-4)
occurs at higher field than in the corresponding a-anomers,
due to the shielding effect exerted by the phenyl ring. For
the same reason, in the a anomers the pyrimidinyl proton
H-6 or the purinic proton H-8 undergo upfield shifts with
respect to the corresponding b-anomers.
Furthermore, the assignment of N-1/N-3 or N-7/N-9
substitution for pyrimidine or purine nucleosides was done
by 2D-NMR experiments of (13C–1H) HMBC, as depicted
in Fig. 1.
In particular, for the pyrimidine derivatives, the corre-
lation between the proton H-40 and the carbon C-6 of the
nucleobase was diagnostic of N-1 substitution. Similarly,
for the purine derivatives, the correlation between the
proton H-40 and the quaternary carbon C-4 of the nucle-
obase was employed to identify N-9 regioisomers. The
assignment of N-9 or N-7 substitution was also confirmed
by UV analysis: kmax of N-9 and N-7 isomers was 265 and
273 nm, respectively, in accordance with previously
reported data (Franchini et al. 2012; Jeong et al. 1993).
X-ray crystallography
In order to confirm the structural and configurational data,
the structures of the racemates 32a and 32b were determined
by X-ray crystallography, as shown in Fig. 2. From water
solution, 32a grows as colourless plates belonging to tri-
clinic space group P-1. The structure is heavily disordered
and the asymmetric unit comprises the two enantiomers of
the compound in 1:1 ratio and sharing the same crystallo-
graphic site (Fig. 2a). The two molecules (A and B) have
coinciding phenyl substituents (within experimental
Scheme 2 Reagents and conditions: (i) NH3/MeOH, r.t., 12 h, 60 % for 19a and 64 % for 19b, 74 % for 20a and 72 % for 20b, 66 % for 21a
and 95 % for 21b; (ii) NH3/MeOH, reactor, 90 C, 12 h, 52 % for 22a and 60 % for 22b, or NaOH sol., MeOH, reflux, 12 h, 44 % for 23a and
73 % for 23b
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resolution), slightly shifted thymine groups and 2-(hydrox-
ymethyl)-1,3-dioxolan-4-yl moieties with significantly dif-
ferent conformations (Table S4). The five-membered ring of
molecule A is twisted, with the largest endocyclic torsion
angle around the C-50–O-10 bond (m2 = 32.4(8)). By con-
trast, molecule B features an envelope conformation on C-50,
with a torsion angle m4 = -3.6(9) around C-20–O-30 bond.
In both molecules, the thymine and hydroxymethyl groups
are in axial positions, whereas the phenyl substituent is
bisectional. The glycosidic bond lengths average to 1.480(5)
A˚ and glycosidic torsion angles are vA = -138.1(3) and
vB = -174.8(4), indicating –ac and –ap orientations of the
thymine group (the sign of torsion angles in this section is
appropriate for enantiomers with an R configuration at the
glycosidic carbon atom, as in Fig. 2b) (Norbeck et al. 1989;
Kim et al. 1992a, b).
Compound 32b was isolated from H2O solution as
colorless needles of the monohydrate. Crystals of
32bH2O are triclinic, space group P-1, and the unit cell
comprises two molecules related by an inversion center
(Fig. 2b). The 1,3-dioxolane ring adopts a twisted con-
formation (Table S4), the largest endocyclic torsion angle
being found around the C-50–O-10 bond (m2 =
39.34(14)), as in molecule A of 32a. The thymine sub-
stituent is in axial position, with a glycosidic bond length
of 1.4812(19) A˚, hence identical to that found in 32a. The
hydroxymethyl and phenyl substituents are in bisectional
and axial positions, respectively. The torsion angle at the
glycosidic bond (v = -82.97(16)) is smaller (in absolute
value) than in 32a, indicating a –sc orientation for the
thymine substituent. This contrasts with the anti-confor-
mation found in the b isomer of Dioxolane-T in both
enantiomerically-pure (Kim et al. 1992a, b) and racemic
form (Norbeck et al. 1989). The hydroxymethyl sub-
stituent in the two compounds is found in ± sc orientation
with |c|*60, indicating the typical gauche–gauche con-
formation (Norbeck et al. 1989; Kim et al. 1992a, b).
In spite of the aforementioned disorder effects, the
crystal lattice of 32a entails a well-defined pattern of
hydrogen bonds. Base-pairing interactions link molecules
Scheme 3 Reagents and conditions: (i) KOAc, 18-Crown-6, DMF, reflux, 6 h, 27 % for 26a and 26 % for 26b, 41 % for 27a and 14 % for 27b,
16 % for 28a and 44 % for 28b, 20 % for 29a and 40 % for 29b, 35 % for 30a and 10 % for 30b; (ii) NH3/MeOH, reactor, 90 C, 12 h, 80 % for
24 or NaOH sol., MeOH, reflux, 12 h, 67 % for 25; (iii) NH3/MeOH, r.t., 12 h, 99 % for 31a and 99 % for 31b, 88 % for 32a and 65 % for 32b,
52 % for 33a and 62 % for 33b, 41 % for 34a and 45 % for 34b, 99 % for 35a and 71 % for 35b
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into dimers across inversion centers. Complementary
hydrogen bonds between carbonyl and hydroxyl groups
afford chains of coplanar dimers, which interact laterally
via hydrophobic contacts to give sheets parallel to (121)
planes. Neighboring sheets are linked primarily by base-
stacking interactions.
In the crystal lattice of 32bH2O, molecules are exten-
sively hydrogen bonded to give sheets oriented parallel to
the (001) planes. Complementary hydrogen-bond donor–
acceptor interactions link molecules of 32b into
centrosymmetric dimers, with N-3–H-3*O-2 2.8502(17)
A˚. Dimers related by unitary translation along the b-axis
interact via two water molecules, each of which donates
two hydrogen bonds to thymine and hydroxymethyl oxy-
gens [Ow–Hw1O-4 2.03(3) A˚, Ow–Hw2*O-60 1.92(3)
A˚]. Base-stacking interactions and an additional hydrogen
bond between the water molecule and the hydroxymethyl
Fig. 1 Significant NOESY and HMBC correlations for exemplary a, N-1/N-9 and b, N-1/N-9 isomers
Table 1 Relevant 1H chemical shifts (in d) and multiplicity of
compounds 19–23
Compound Base CH3 Dd CH2OH Dd
19a U 1.42 (s) 0.16 3.30, 3.40 (dd) 0.11
19b U 1.26 (s) 3.51 (d)
20a T 1.42 (s) 0.15 3.29, 3.40 (dd) 0.12
20b T 1.27 (s) 3.52 (d)
21a C 1.42 (s) 0.16 3.32, 3.42 (dd) 0.06
21b C 1.26 (s) 3.48 (d)
22a A 1.38 (s) 0.06 3.31–3.42 (m) 0.07
22b A 1.32 (s) 3.49 (m)
23a G 1.35 (s) 0.08 3.31–3.41 (m) 0.07
23b G 1.27 (s) 3.48 (d)
400 MHz, DMSO-d6 solvent, TMS reference
Table 2 Relevant 1H chemical shifts (in d) and multiplicity of
compounds 31–35
Compound Base H-4a Dd H-6b or H-8c Dd
31a U 6.49 (dd) 0.29 6.98 (d) 1.10
31b U 6.20 (dd) 8.08 (d)
32a T 6.49 (dd) 0.28 6.75 (s) 1.22
32b T 6.21 (dd) 7.97 (s)
33a C 6.47 (dd) 0.29 6.99 (d) 1.10
33b C 6.18 (dd) 8.09 (d)
34a A 6.65 (dd) 0.21 7.53 (s) 0.94
34b A 6.44 (dd) 8.47 (s)
35a G 6.43 (dd) 0.25 7.10 (s) 0.96
35b G 6.18 (dd) 8.04 (s)
400 MHz, DMSO-d6 solvent, TMS reference
a Dioxolane
b Pyrimidine
c Purine
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group [O-60–H-60*Ow 1.89(3) A˚] link neighboring
dimers related by unitary translation along the a-direction
(an asterisk is used to label atoms belonging to asymmetric
units other than that shown in Fig. 2b). These hydrogen-
bonded sheets alternate along the c axis with hydrophobic
layers comprising phenyl substituents. Additional details
on intermolecular contacts are provided in Supplementary
Materials.
Biological activity
The compounds were tested in cell-based assays against
human immunodeficiency virus type-1 (HIV-1) and
BVDV. Efavirenz and 20-C-methyl-guanosine were used as
reference inhibitors, respectively. The cytotoxicity against
the cells lines supporting the viral replication was evalu-
ated in parallel with the antiviral activity. All compounds
showed no cytotoxicity against MT4 or MDBK cells.
However, only 23a weakly inhibited the HIV-1
multiplication (EC50 = 52 lM) whereas none of them
showed anti-BVDV activity (Table S5).
The title compounds were also evaluated in vitro against
representatives of Gram negative (Salmonella spp) and
Gram positive (S. aureus) bacteria and human pathogenic
fungi (Candida albicans). Miconazole and Streptomycin
were used as reference compounds in antimycotic and
antibacterial assays, respectively. None of the compounds
showed antimicrobial activity (Table S6 in Supplementary
Materials).
Lastly, the compounds were assayed for cytotoxic
effects in several human cancer cell lines such as colon
cancer (HCT116), lung cancer (A549), stomach cancer
(SNU638), prostate cancer (PC-3) and human liver cancer
(SK-Hep-1) cells, using the sulforhodamine B (SRB) pro-
tein staining method as reported in Table 3 (Lee et al.
2002).
Most of the compounds showed a non-significant anti-
tumor activity with an IC50[ 100 lM. Only 21b showed
Fig. 2 Partially-labelled ORTEP-3 plots of racemates 32a (a) and 32 bH2O (b) with displacement ellipsoids at 40 % probability level and H
atoms drawn as spheres with arbitrary radius. The atom labelling scheme is the same used in Fig. 1. Ow, Hw1 and Hw2 are atoms of the lattice
water molecule. In a, the two molecules (A and B) have opposite absolute configurations and share the same crystallographic site but are drawn
separately for clarity. In b, the two positions of the disordered phenyl ring are drawn using solid and open bonds
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moderate activity against human liver (IC50 = 7.1 lM),
stomach (IC50 = 8.6 lM), lung (IC50 = 18.9 lM) and
colon (IC50 = 21.7 lM) cancer cell lines. These data are in
accordance with previously published studies (Liu et al.
2001). Noteworthy, compounds 22a and 32a demonstrated
residual anticancer activity (IC50(A549) = 66.9 and
IC50(SNU638) = 74.6 lM, respectively) which, interest-
ingly, is linked to the unnatural a configuration.
Theoretical calculations
In order to gain insight into the scarce antiviral activity
observed in the cell-based assays, molecular orbital cal-
culations were performed. It is known that kinases display
a substrate preference for South (S) type conformation
while DNA polymerases almost exclusively incorporate the
North (N) triphosphate (Marquez et al. 2004, 2006).
Moreover, it has been reported that syn- and anti-confor-
mation around the N-glycosyl bond plays a critical role for
the binding of ligands to the proper enzyme (El Kouni et al.
1996). In particular, several crystal structures of nucleoside
kinases show the nucleobase in the anti conformation (Kim
et al. 1992a, b; Norbeck et al. 1989). Thus, the relative
energies of N and S conformers were determined as a
function of the torsion angle (v) around the glycosidic bond
for the reference compound Dioxolane-T and its analogues,
20b and 32b (Fig. 3).
In particular a single enantiomer (20R, 40R) of Diox-
olane-T, 20b and 32b was employed (in this section we
adopt the same atom numbering scheme as in Structural
Table 3 Cell viability (IC50) of 26–45 determined by Sulforhodamine B assay after 72 h incubation
Compound R Base IC50 lM
HCT116 PC3 A549 SNU638 SK-Hep-1
19a CH3 U [100 [100 [100 [100 [100
19b CH3 U [100 [100 [100 [100 [100
20a CH3 T [100 [100 [100 [100 [100
20b CH3 T [100 [100 [100 [100 [100
21a CH3 C [100 [100 [100 [100 [100
21ba,b CH3 C 21.7 [100 18.9 8.6 7.1
22a CH3 A 80.3 [100 66.9 84.4 71
22b CH3 A [100 [100 [100 [100 [100
23a CH3 G [100 [100 [100 [100 [100
23b CH3 G [100 [100 [100 [100 [100
31a C6H5 U [100 [100 [100 [100 [100
31b C6H5 U [100 [100 [100 [100 [100
32a C6H5 T [100 [100 97.4 74.6 [100
32b C6H5 T [100 [100 [100 [100 [100
33a C6H5 C – – – – –
33b C6H5 C [100 [100 [100 [100 [100
34a C6H5 A [100 [100 [100 [100 [100
34b C6H5 A [100 [100 [100 [100 [100
35a C6H5 G [100 [100 [100 [100 [100
35b C6H5 G [100 [100 [100 [100 [100
etoposide 1.3 20.0 0.4 0.4 0.2
Dioxolane-C H b C 0.1 [100 0.4 95.5 \0.8
HCT116 human colon cancer cell line, PC3 human prostate cancer cell line, A549 human lung cancer cell line, SNU638 human stomach cancer
cell line, SK-Hep-1 human liver cancer cell line activity
Cell proliferation was determined as follows: cell proliferation (%) = (average absorbance compound - average absorbance day zero)/(average
absorbance control - average absorbance day zero) 9 100
IC50 values were calculated by nonlinear regression analysis using TableCurve 2D v5.01 (Systat Sofrware Inc., Richmond, CA, USA)
a Franchini and Brasili (1997)
b Li uet al. (2001)
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characterization). In the N- and S- type conformers the
dihedral angle m2 = C40–C50–O10–C20 was fixed at 42 and
-42, respectively, as previously reported (Norbeck et al.
1989; Kubota et al. 2013). Rotational energies around the
N-glycosyl bond O30–C40–N1–C2 were then calculated for
both conformers at the HF/3-21G* level employing
Gaussian 09 program.
As expected the North or South conformation of the
ribose influences the conformation of the nucleobase (syn
or anti) relative to the sugar moiety (Saenger 1984).
According to our calculations Dioxolane-T adopts N-type
puckering and anti-orientation (v*180) as the preferen-
tial conformation. This result is qualitatively consistent
with the solid state structure of Dioxolane-T in both
enantiomerically-pure and racemic forms (Norbeck et al.
1989) (see Table S4). Significantly, the introduction of the
methyl or phenyl substituent has no influence on the
preferential conformation of the dioxolane ring obtained by
theoretical calculations, which remains the same as for
Dioxolane-T. Notice, however, that the crystal structure of
32bH2O reveals an N-type puckering but a syn orientation,
even though with a large |v| value (Table S4). The con-
formational data obtained for 20b and 32b thus reveal a
similar conformational landscape as in Dioxolane-T. In
particular, for the new compounds, the energy difference
between the S-anti and N-anti conformations is comparable
or lower than found in Dioxolane-T.
However, although the S-anti conformation appears to
be stable enough to be processed by the cellular kinases,
the monophosphate formation, which has often been found
to be the rate-limiting step, could be strongly inhibited by
the steric hindrance of the substituent at position 40. In this
regard it would be interesting to prepare some
monophosphate-prodrugs to see if, by overcoming the first
phosphorylation step, these compounds would gain some
biological activity (Perrone et al. 2007; McGuigan et al.
2009).
In summary, we efficiently synthesized 40-C-methyl and
-phenyl 1,3-dioxolane-based pyrimidine and purine ana-
logues. The synthetic approach has provided good yields of
the desired products both as a and b anomers. Additionally,
we have reported conformational and configurational
studies, supported by NMR and X-ray crystallography, for
this new class of compounds. The evaluations of the bio-
logical activity revealed only a weak anti-HIV-1 activity of
compound 23a. Furthermore 22a and 32a demonstrated
residual anti-proliferative activity, interestingly linked to
the unnatural a configuration. Although active compounds
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Fig. 3 Relative energies in kcal/mol of canonical conformations of Dioxolane-T (DOT) and compounds 20b, 32b, obtained by theoretical
calculations
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were not obtained, there is no doubt that the accumulation
of SAR studies, including this, may provide structural
insights for the design of active antiviral and antitumor
agents. Moreover, the synthetic strategy presented here
could represent a versatile approach to obtain both a and b
anomers of different 40-C-substituted dioxolane-based
nucleosides.
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